See more : FaZe Holdings Inc. (FAZEW) Income Statement Analysis – Financial Results
Complete financial analysis of G Medical Innovations Holdings Ltd (GMVD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of G Medical Innovations Holdings Ltd, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Jentayu Sustainables Berhad (5673.KL) Income Statement Analysis – Financial Results
- Demae-Can Co.,Ltd (2484.T) Income Statement Analysis – Financial Results
- Shikun & Binui Ltd. (SKBNF) Income Statement Analysis – Financial Results
- Formosa Chemicals & Fibre Corporation (1326.TW) Income Statement Analysis – Financial Results
- Edify Acquisition Corp. (EAC) Income Statement Analysis – Financial Results
G Medical Innovations Holdings Ltd (GMVD)
About G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.42M | 5.06M | 4.90M | 5.53M | 3.06M | 109.00K | 0.00 |
| Cost of Revenue | 3.64M | 3.56M | 4.23M | 5.75M | 4.03M | 1.16M | 0.00 |
| Gross Profit | 784.00K | 1.50M | 667.00K | -223.00K | -969.00K | -1.05M | 0.00 |
| Gross Profit Ratio | 17.74% | 29.70% | 13.61% | -4.04% | -31.65% | -959.63% | 0.00% |
| Research & Development | 2.29M | 1.68M | 1.32M | 2.55M | 243.00K | 186.00K | 0.00 |
| General & Administrative | 24.86M | 9.01M | 7.66M | 10.00M | 12.61M | 24.01M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 3.46M | 664.00K | 356.00K | 0.00 |
| SG&A | 24.86M | 9.01M | 7.66M | 10.00M | 13.27M | 24.36M | 0.00 |
| Other Expenses | 1.05M | 854.00K | 3.70M | 0.00 | 2.70M | 0.00 | 0.00 |
| Operating Expenses | 28.19M | 11.54M | 12.67M | 12.56M | 16.22M | 25.48M | 0.00 |
| Cost & Expenses | 31.83M | 15.10M | 16.90M | 18.30M | 28.69M | 26.63M | 0.00 |
| Interest Income | 0.00 | 870.00K | 344.00K | 263.00K | 858.00K | 282.00K | 0.00 |
| Interest Expense | 0.00 | 4.49M | 750.00K | 3.85M | 995.00K | 923.00K | 0.00 |
| Depreciation & Amortization | -10.34M | 1.00M | 3.61M | 2.01M | 2.61M | 176.00K | 22.82K |
| EBITDA | -37.75M | -9.04M | -8.40M | -12.52M | -13.71M | -26.06M | 0.00 |
| EBITDA Ratio | -854.10% | -178.67% | -171.39% | -226.49% | -447.88% | -23,911.01% | 0.00% |
| Operating Income | -27.41M | -10.04M | -12.00M | -14.53M | -16.33M | -26.24M | 0.00 |
| Operating Income Ratio | -620.14% | -198.44% | -244.98% | -262.87% | -533.18% | -24,072.48% | 0.00% |
| Total Other Income/Expenses | 13.47M | -3.62M | -702.00K | -3.58M | -137.00K | -923.00K | 0.00 |
| Income Before Tax | -13.94M | -14.89M | -12.71M | -16.36M | -17.32M | -27.16M | 0.00 |
| Income Before Tax Ratio | -315.43% | -294.40% | -259.31% | -296.11% | -565.68% | -24,919.27% | 0.00% |
| Income Tax Expense | 16.00K | -3.00K | -18.00K | -857.00K | -345.00K | 85.00K | 0.00 |
| Net Income | -13.96M | -14.89M | -12.69M | -15.51M | -16.98M | -27.25M | 0.00 |
| Net Income Ratio | -315.79% | -294.35% | -258.94% | -280.60% | -554.41% | -24,997.25% | 0.00% |
| EPS | 0.00 | -45.89 | -60.40 | -7.00 | -8.60 | -20.39 | 0.00 |
| EPS Diluted | 0.00 | -45.89 | -60.40 | -7.00 | -8.60 | -20.39 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 324.45K | 210.07K | 2.21M | 1.97M | 1.34M | 71.11M |
| Weighted Avg Shares Out (Dil) | 0.00 | 324.45K | 210.07K | 2.21M | 1.97M | 1.34M | 71.11M |
G Medical Innovations Holdings Ltd. Announces a Partnership with Peter N Nielsen to Drive Health and Wellness Innovation
Why IS G Medical Innovations (GMVD) Stock Up 34% Today?
G Medical Innovations Will Provide Services to Veterans and Military Personnel by Partnering With Resilient Support Services
Why Is G Medical Innovations (GMVD) Stock Up 32% Today?
G Medical Innovations' CEO Issues Update to Shareholders, August 2023
Top 5 Health Care Stocks That Could Blast Off In August
7 Doomed Stocks Destined for Disaster
Best Penny Stocks To Buy Now? 3 To Watch Today
3 Tips for Using Technical Indicators to Find Penny Stocks to Buy
Why Is G Medical Innovations (GMVD) Stock Up 94% Today?
Source: https://incomestatements.info
Category: Stock Reports